Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-142,188
Closed -$3.01M 1128
2024
Q2
$3.01M Hold
142,188
0.01% 662
2024
Q1
$3.4M Hold
142,188
0.01% 654
2023
Q4
$3.29M Sell
142,188
-114,885
-45% -$1.98M 0.01% 644
2023
Q3
$4.8M Sell
257,073
-9,687
-4% -$261K 0.02% 536
2023
Q2
$8.27M Sell
266,760
-2,593
-1% -$81.2K 0.03% 448
2023
Q1
$8.7M Buy
269,353
+11,080
+4% +$390K 0.03% 441
2022
Q4
$8.36M Buy
258,273
+2,245
+0.9% +$60.9K 0.03% 474
2022
Q3
$6.52M Sell
256,028
-1,573
-0.6% -$39.3K 0.03% 522
2022
Q2
$6.44M Sell
257,601
-4,238
-2% -$93.3K 0.02% 520
2022
Q1
$6.9M Sell
261,839
-15,005
-5% -$460K 0.02% 562
2021
Q4
$11.5M Buy
+276,844
New +$16.4M 0.03% 455

Other funds holding PHR

Axa's PHR Position: Q3 2024 in Review

Axa sold out of Phreesia (PHR) in Q3 2024, closing a stake of 142,188 shares — an estimated $3.01M sold.

Axa first reported a position in PHR in Q4 2021 and held it in 11 quarters. The position peaked at $11.5M in Q4 2021. 191 funds tracked by Wall St. Rank hold PHR as of Q3 2024.

  • Axa reported no remaining Phreesia position as of Q3 2024 after selling out during the quarter.
  • Axa sold 142,188 Phreesia shares in Q3 2024, an estimated $3.01M.
  • Axa first reported a position in Phreesia in Q4 2021 and held it in 11 quarters.
  • Axa's Phreesia position peaked at $11.5M in Q4 2021.
  • 191 funds tracked by Wall St. Rank held Phreesia as of Q3 2024.

Based on Axa's 13F filing for Q3 2024, filed 14 Nov 2024.